Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2018 | Research

Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment

Authors: Xu Li, Wenxiang Wang, Yong Zhou, Desong Yang, Jie Wu, Baihua Zhang, Zhining Wu, Jinming Tang

Published in: World Journal of Surgical Oncology | Issue 1/2018

Abstract

Background

This study aimed to propose a new surgical strategy, i.e., the transcervical video-assisted mediastinoscopic lymphadenectomy (VAMLA) with esophagectomy via the left transthoracic approach for patients with esophageal cancer (EC), and to compare the outcomes with those of esophagectomy via the right thoracic approach.

Methods

From December 2014 to March 2016, 49 cases were enrolled in this non-randomized concurrent control study. Twenty-eight patients with EC who underwent transcervical VAMLA with esophagectomy via the left transthoracic approach were assigned into the study group, while 21 EC patients undergoing esophagectomy via the right transthoracic approach during the same period were enrolled into the control group. Operative outcomes including operative time, the numbers of removed lymph nodes, intraoperative blood loss, the length of hospital stay, and postoperative complications in both groups were evaluated and compared.

Results

There were no significant differences in the baseline profiles between the two groups, and all patients in the two groups successfully underwent the surgery. There was a significant difference between transcervical VAMLA with esophagectomy via the left thoracic approach and esophagectomy via the right thoracic approach with regard to the number of all dissected lymph nodes [(29.0 ± 8.7) vs. (17.8 ± 8.1), p < 0.05], dissected superior mediastinal lymph nodes [(11.2 ± 5.0) vs. (3.7 ± 2.9), p < 0.05], and dissected in the recurrent laryngeal nerve lymph nodes [(5.6 ± 3.5) vs. (2.3 ± 2.1), p < 0.05]. No significant differences were observed in the operative time, intraoperative blood loss, length of postoperative hospital stay, number of dissected abdominal lymph nodes, postoperative pulmonary complications (pneumonia and atelectasis), anastomotic fistula, chylothorax, and vocal cord paralysis (p > 0.05).

Conclusion

Transcervical VAMLA combined with esophagectomy via the left thoracic approach appears technically feasible and safe and shows advantages in the number of dissected superior mediastinal lymph nodes, suggesting that it may serve as a new treatment option for patients with esophageal carcinoma.

Sohda M, Kuwano H. Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg. 2016; https://doi.org/10.5761/atcs.ra.16-00162.

Garcia B, Goodman KA, Cambridge L, Dunphy M, Wu AJ. Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation. Radiat Oncol. 2016;11(1):156. https://doi.org/10.1186/s13014-016-0731-6.CrossRefPubMedPubMedCentral

Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol. 2010;95(2):229–33. https://doi.org/10.1016/j.radonc.2010.01.006.CrossRefPubMed

Martin-Richard M, Diaz Beveridge R, Arrazubi V, Alsina M, Galan Guzman M, Custodio AB, et al. SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). Clin Transl Oncol. 2016;18(12):1179–86. https://doi.org/10.1007/s12094-016-1577-y.CrossRefPubMedPubMedCentral

Ma Q, Liu W, Long H, Rong T, Zhang L, Lin Y, et al. Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma. J Cardiothorac Surg. 2015;10(1):123.CrossRefPubMedPubMedCentral

Fujiwara H, Shiozaki A, Konishi H, Kosuga T, Komatsu S, Ichikawa D, et al. Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer. Dis Esophagus. 2017;30(10):1–8. https://doi.org/10.1093/dote/dox047.CrossRefPubMed

Goto H, Tokunaga M, Miki Y, Makuuchi R, Sugisawa N, Tanizawa Y, et al. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer. 2014;18(2):1–7.

Mori K, Yamagata Y, Aikou S, Nishida M, Kiyokawa T, Yagi K, et al. Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery. Dis Esophagus. 2016;29(5):429–34. https://doi.org/10.1111/dote.12345.CrossRefPubMed

Biere SS, Henegouwen MIVB, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):465–6.CrossRef

10.

Koyanagi K, Igaki H, Iwabu J, Ochiai H, Tachimori Y. Recurrent laryngeal nerve paralysis after esophagectomy: respiratory complications and role of nerve reconstruction. Tohoku J Exp Med. 2015;237(1):1–8.CrossRefPubMed

11.

Mimatsu K, Oida T, Kawasaki A, Aramaki O, Kuboi Y, Kanou H, et al. Mediastinoscopy-assisted esophagectomy is useful technique for poor surgical-risk patients with thoracic esophageal cancer. Surg Laparosc Endosc Percutan Tech. 2009;19(1):e17–20.CrossRefPubMed

12.

Bumm R, Feussner H, Bartels H, Stein H, Dittler H, Höfler H, et al. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg. 1997;21(8):822–31.PubMed

13.

Ikeda Y, Niimi M, Kan S, Takami H, Kodaira S. Thoracoscopic esophagectomy combined with mediastinoscopy via the neck. Ann Thorac Surg. 2002;73(4):1329–31.CrossRefPubMed

14.

Luketich JD, Alvelorivera M, Buenaventura PO, Christie NA, Mccaughan JS, Litle VR, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238(4):494–5.

15.

Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245(5):717–25. https://doi.org/10.1097/01.sla.0000251703.35919.02.CrossRefPubMedPubMedCentral

16.

Siewert JR, Stein HJ. Lymph-node dissection in squamous cell esophageal cancer—who benefits? Langenbeck's Arch Surg. 1999;384(2):141–8.CrossRef

17.

Witte B, Wolf M, Huertgen M, Toomes H. Video-assisted mediastinoscopic surgery: clinical feasibility and accuracy of mediastinal lymph node staging. Ann Thorac Surg. 2006;82(82):1821–7.CrossRefPubMed

18.

Ainbinder DJ, Esmaeli B, Groo SC, Finger PT, Brooks JP. Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual. Arch Pathol Lab Med. 2009;133(8):1256–61. https://doi.org/10.1043/1543-2165-133.8.1256.PubMed

19.

Nachar N. The Mann-Whitney U: a test for assessing whether two independent samples come from the same distribution. Tutorials Quant Methods Psychol. 2008;4(1):13–20.CrossRef

20.

Wang W, Sun XW, Li CF, Lv L, Li YF, Chen YB, et al. Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Ann Surg Oncol. 2011;18(4):1060–7.CrossRefPubMed

21.

Jr MC. Multidisciplinary management of esophageal cancer. Surg Oncol Clin N Am. 2013;22(2):217–46.CrossRef

22.

Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68–74.CrossRefPubMed

23.

Altorki N, Harrison S. What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer? Ann Cardiothorac Surg. 2017;6(2):167.CrossRefPubMedPubMedCentral

24.

Kumagai K, Rouvelas I, Tsai J, Mariosa D, Klevebro F, Lindblad M, et al. Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg. 2014;101(4):321–38.CrossRefPubMed

25.

Na DK, Choi YJ, Choi SH, Kook SH, Park HJ. Evaluation of cervical lymph node metastasis in thyroid cancer patients using real-time CT-navigated ultrasonography: preliminary study. Ultrasonography. 2015;34(1):39.CrossRefPubMed

26.

Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann Surg. 2009;250(2):206–9. https://doi.org/10.1097/SLA.0b013e3181b16cd1.CrossRefPubMed

27.

Akutsu Y, Matsubara H. Lymph node dissection for esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61(7):397–401. https://doi.org/10.1007/s11748-013-0237-1.CrossRefPubMed

28.

Wu N, Chen Z, Pang L, Ma Q, Chen G. Prognostic significance of lymph node characteristics on survival in esophageal squamous cell carcinomas. Wien Klin Wochenschr. 2013;125(1–2):26–33. https://doi.org/10.1007/s00508-012-0310-2.CrossRefPubMed

29.

Liu YP, Ma L, Wang SJ, Chen YN, Wu GX, Han M, et al. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol. 2010;36(2):155–9. https://doi.org/10.1016/j.ejso.2009.09.005.CrossRefPubMed

30.

Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;92(3):1091–7. https://doi.org/10.1016/j.athoracsur.2011.03.093.CrossRefPubMed

31.

Li CL, Zhang FL, Wang YD, Han C, Sun GG, Liu Q, et al. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013;5(1):355–9. https://doi.org/10.3892/ol.2012.946.CrossRefPubMed

32.

Taniyama Y, Nakamura T, Mitamura A, Teshima J, Katsura K, Abe S, et al. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2013;95(6):1930–7. https://doi.org/10.1016/j.athoracsur.2013.03.069.CrossRefPubMed

33.

Li H, Yang S, Zhang Y, Xiang J, Chen H. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma. J Surg Oncol. 2012;105(6):548–52. https://doi.org/10.1002/jso.22148.CrossRefPubMed

34.

Ye K, Xu JH, Sun YF, Lin JA, Zheng ZG. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma. Genet Mol Res. 2014;13(13):6411–9.CrossRefPubMed

35.

Tan Z, Ma G, Zhao J, Bella AE, Rong T, Fu J, et al. Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg. 2014;18(1):187–93.CrossRefPubMed

36.

Matsuda S, Takeuchi H, Kawakubo H, Shimada A, Fukuda K, Nakamura R, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine. 2016;95(24):e3839. https://doi.org/10.1097/MD.0000000000003839.

37.

Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw. 2011;9(8):830–87.CrossRef

38.

Tabira Y, Yasunaga M, Tanaka M, Nakano K, Sakaguchi T, Nagamoto N, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg. 2000;191(3):232–7.CrossRefPubMed

39.

Buess G, Becker HD. [Minimally invasive surgery in tumors of the esophagus]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Forsh Chir. 1990;118:1355-60.

40.

Akif T, Ahmet D, Serkan O, Buge O, Atilla G, Kamil K. Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013;146(4):774–80.CrossRef

41.

Feng MX, Wang H, Zhang Y, Tan LJ, Xu ZL, Wang Q. Minimally invasive esophagectomy for esophageal squamous cell carcinoma: a case-control study of thoracoscope versus mediastinoscope assistance. Surg Endosc. 2012;26(6):1573–8.CrossRefPubMed

42.

Zhai C, Liu Y, Li W, Xu T, Yang G, Lu H, et al. A comparison of short-term outcomes between Ivor-Lewis and McKeown minimally invasive esophagectomy. J Thorac Dis. 2015;7(12):2352–8.PubMedPubMedCentral

43.

Schmidt J, Irouschek A, Heinrich S, Oster O, Klein P, Birkholz T. Recurrent laryngeal nerve monitoring during esophagectomy and mediastinal lymph node dissection: a novel approach using a single-lumen endotracheal EMG tube and the EZ-blocker. World J Surg. 2012;36(12):2946–7.CrossRefPubMed

44.

Paleru C, Dănăilă O, Bolca C, Cordoş I. Complications of mediastinoscopy. Pneumologia. 2009;58(58):39–40. 2PubMed

45.

Boone J, Livestro DP, Elias SG, Borel Rinkes IH, Van Hillegersberg R. International survey on esophageal cancer: part I surgical techniques. Dis Esophagus. 2009;22(3):195–202.CrossRefPubMed

Title: Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment
Authors: Xu Li
Wenxiang Wang
Yong Zhou
Desong Yang
Jie Wu
Baihua Zhang
Zhining Wu
Jinming Tang
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-017-1268-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

MiR-218 produces anti-tumor effects on cervical cancer cells in vitro

Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes

The role of surgical treatment in isolated organ recurrence of esophageal cancer—a systematic review of the literature

Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer

The efficiency of electronic list-based multidisciplinary team meetings in management of gastrointestinal malignancy: a single-center experience in Southern China